Cholesterol and Lipids - What's new? PCSK9 inhibitors
Endocrinologist Dr Philip Kelly of LondonSwissMedical discusses therapy for lipid disorders including new treatments to keep the risk of car
Thirst and passing too much water
Differentiating the causes of thirst and polyuria is critical as the treatment is completely different dependent on the cause. Diabetes mell
Heavy periods - menorrhagia, what can I do about them?
Dr Philip Kelly discusses the options for patients with heavy periods, including simple non-hormonal options, hormonal treatment, interventi
Canagliflozin for Type 2 Diabetes - reduces cardiovascular events.
Canagliflozin reduces major adverse cardiovascular events (MACE) in patients with T2DM. Big paper in the NEJM, (the trials sponsored by...
Thyroid Eye Disease/ Graves' Ophthalmopathy - new treatment being studied
Teprotumumab is a new monoclonal antibody against the IGF-I receptor that has shown promise at reducing proptosis in moderate to sever Grave
Graves Hyperthyroidism - information for patients
Dr Philip Kelly, consultant endocrinologist at King's College Hospital discusses Graves' thyrotoxicosis, what is it, how does it pre